NASDAQ

Gain Therapeutics, Inc. (GANX)

♥ 511 Thanks from members

Live price chart, market sentiment, and community perspectives for Gain Therapeutics, Inc. (NASDAQ: GANX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Eric KlemFounder: Jean-Edouard ChabannesLeadership: Khalid Islam (Chairman)Leadership: Allan Shaw (CEO)Holder: Vanguard GroupHolder: BlackRockHolder: Baker Bros. AdvisorsGT-02287Mitochondrial Target Therapies#GANX#Gain Therapeutics#Biotech stock#CNS disorders#Rare diseases